BayBridge Capital Group LLC Has $224,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

BayBridge Capital Group LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCA) by 78.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 745 shares of the company’s stock after selling 2,740 shares during the quarter. BayBridge Capital Group LLC’s holdings in HCA Healthcare were worth $224,000 as of its most recent SEC filing.

Several other institutional investors have also recently made changes to their positions in HCA. Mather Group LLC. boosted its stake in shares of HCA Healthcare by 39.3% in the 3rd quarter. Mather Group LLC. now owns 1,208 shares of the company’s stock worth $491,000 after buying an additional 341 shares during the last quarter. Atomi Financial Group Inc. purchased a new stake in shares of HCA Healthcare during the 3rd quarter valued at $233,000. Brookstone Capital Management increased its holdings in HCA Healthcare by 0.7% during the third quarter. Brookstone Capital Management now owns 4,065 shares of the company’s stock worth $1,652,000 after buying an additional 30 shares during the last quarter. Daymark Wealth Partners LLC grew its position in shares of HCA Healthcare by 12.1% during the 3rd quarter. Daymark Wealth Partners LLC now owns 2,583 shares of the company’s stock valued at $1,050,000 after acquiring an additional 279 shares during the period. Finally, CWM LLC lifted its stake in HCA Healthcare by 4.3% in the third quarter. CWM LLC now owns 10,288 shares of the company’s stock valued at $4,181,000 after purchasing an additional 421 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In other HCA Healthcare news, SVP Phillip G. Billington sold 3,897 shares of the business’s stock in a transaction on Thursday, November 14th. The stock was sold at an average price of $350.00, for a total value of $1,363,950.00. Following the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Erol R. Akdamar sold 2,900 shares of the company’s stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now owns 6,843 shares in the company, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.70% of the company’s stock.

HCA Healthcare Price Performance

Shares of HCA stock opened at $321.95 on Friday. The business’s 50 day moving average price is $313.85 and its 200-day moving average price is $353.37. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $417.14. The firm has a market cap of $81.55 billion, a P/E ratio of 14.65, a P/E/G ratio of 1.13 and a beta of 1.64. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same quarter last year, the business posted $5.90 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date is Monday, March 17th. This represents a $2.88 dividend on an annualized basis and a yield of 0.89%. HCA Healthcare’s dividend payout ratio is 12.02%.

Analyst Upgrades and Downgrades

HCA has been the subject of several research reports. Barclays cut their price target on HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research note on Monday, January 27th. KeyCorp lowered their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating on the stock in a report on Tuesday, January 7th. Truist Financial dropped their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. TD Cowen cut their price target on shares of HCA Healthcare from $450.00 to $440.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Finally, JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research note on Tuesday, December 17th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have assigned a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.